Capricor Therapeutics
CAPR
#7980
Rank
ยฃ0.21 B
Marketcap
ยฃ4.77
Share price
-4.36%
Change (1 day)
-59.68%
Change (1 year)

Revenue for Capricor Therapeutics (CAPR)

Revenue in 2025 (TTM): ยฃ8.86 Million

According to Capricor Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ8.34 Million. In 2024 the company made a revenue of ยฃ17.74 Million a decrease over the revenue in the year 2023 that were of ยฃ19.76 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Capricor Therapeutics from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ8.86 M-50.02%
2024 ยฃ17.74 M-10.2%
2023 ยฃ19.76 M837.08%
2022 ยฃ2.1 M1062.45%
2021 ยฃ0.18 M-20.29%
2020 ยฃ0.22 M-70.3%
2019 ยฃ0.76 M-41.79%
2018 ยฃ1.31 M-18.76%
2017 ยฃ1.62 M-37.31%
2016 ยฃ2.58 M1.46%
2015 ยฃ2.54 M-4.79%
2014 ยฃ2.67 M
2013 N/A-100%
2012 ยฃ0.12 M-86.12%
2011 ยฃ0.87 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Cytokinetics
CYTK
ยฃ65.39 M 683.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.09 B 827,795.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.01 B 24,002.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.94 M-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA